O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS
暂无分享,去创建一个
N. Jørgensen | F. Knop | B. Ebdrup | N. Bak | B. Broberg | P. L. Ishøy | U. Andersen | R. Eriksson